PunjiPUNJI
Healthcare ServicesSmall Cap

Nureca Limited

NURECA · ISIN: INE0DSF01015

Nureca Limited is a small cap company in the Healthcare Services sector, listed on the NSE under ISIN INE0DSF01015.

Price and day-range figures above come from the latest NSE/BSE close, not a delayed quote. Where shown, RSI (14-day), SMA50/SMA200, and ADX measure momentum and trend from real daily closing prices - an RSI above 70 or below 30 typically signals overbought or oversold conditions, and a price above its SMA200 is a common long-term uptrend marker. ADTV (20-day average daily traded value) reflects real liquidity, not a projection. Fundamentals, when available, come from the company's own filed financials rather than a third-party estimate.

Close (as of 2026-10-29)
₹302.9
+0.8% today
Day Range
₹293.05 - ₹307.95
Market Cap (Small Cap)
₹289.622 Cr
Not enough track record

Price History

CHART

Nureca Limited - growth of ₹100

Growth of ₹100 invested on 2026-09-30, not raw price - the standard way to compare performance regardless of price level. Daily resolution for the last 90 days, weekly up to 2 years, monthly beyond that.

-102050801102026-09-302026-10-062026-10-092026-10-142026-10-192026-10-232026-10-282026-10-29

1M

-17.38%

3M

-11.85%

6M

+13.65%

1Y

-0.91%

3Y CAGR

-3.29%

5Y CAGR

-

Earnings (TTM)

LEARN: Revenue and PAT · EPS · P/E

CHART

Nureca Limited - revenue & profit (TTM)

Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-09-30.

0 Cr49 Cr97 Cr146 Cr195 CrQ3 FY2026Q4 FY2026Q1 FY2027Q2 FY2027
Revenue (TTM)PAT (TTM)

Technicals

Not available for this stock yet.

Shareholding Pattern

Not available for this stock yet.

Corporate Actions

No corporate actions on record for this stock.

Recent Deals

No recent block/bulk/short-sell deals on record for this stock.

Frequently asked questions

What is Nureca Limited's 1-year and 3-year return?

Nureca Limited's 1-year price return is -0.91%. Its 3-year CAGR (annualized return) is -3.29%. Both are price-only returns (no dividends added back), computed from the nearest available trading day to each anniversary - not a forecast of future performance.

What is Nureca Limited's latest financial performance?

Nureca Limited's trailing-twelve-month (TTM) revenue as of 2026-09-30 is ₹174 Cr, with a TTM profit after tax of ₹5 Cr and an EBITDA margin of null%. TTM figures sum the most recent four reported quarters rather than a single quarter, which smooths out seasonal swings in a business's revenue and profit. EPS (earnings per share) over this TTM window is ₹4.92.

Stock data · Not financial advice · Past performance does not indicate future returns